Sentiment Struggles Amid Concerns of 2nd Wave of Infections

European bourses are pointing to a mixed start as investors continue to weigh up the reopening of economies against the prospect of a second wave of infections

Charts (4)

European bourses are pointing to a mixed start as investors continue to weigh up the reopening of economies against the prospect of a second wave of infections and amid strained trade relations, but rebounding oil prices. 

Whilst President Trump has shut the door to the renegotiation of the Phase 1 trade deal terms, China has banned imports of meat from Australia. Strained US – Sino and Sino – Australia relations are dragging on sentiment.

With Germany’s covid-19 reproduction rate, R, now at 1.07, South Korea scrambling to control an outbreak linked to a nightclub in Seoul and China with its first infection in Wuhan since restrictions were lifted, investors are fretting over the possibility of a second wave of infections. That said, New York, the epicentre ion the US is now ready to reopen. As an economic and financial hub, this carries some weight and helped pull the S&P into a positive close on Monday.

The market has clawed back around 50% of March’s losses. Whilst economies are gradually reopening which is a positive, it is become increasingly clear that no quick bounce back is on the cards. This will be a rocky road to recovery and not one that is always pointing higher. 

Oil jumps
Whilst fears of a second wave of infections are causing some unease in the markets, oil prices are a rare source of light. Oil has jumped over 1.2% in early trade following an unexpected commitment from Saudi Arabia to cut oil production to drain some of the global oil glut. A bullish production cut of 1 million barrels per day by Saudi Arabia means that the oil producing giant has cut production by some 40% since April. The move could also go a long way to encourage other OPEC nations to comply with their cut quotas. 

Whilst the cut was overshadowed in the previous session by fears of a second wave of infection, data showing that oil storage had dropped in the US’s largest oil storage at Cushing, Okla, by 2.17 million barrels offers some breathing space amid swirling storage shortage fears.

With supply now being addressed and demand slowly picking up as economies reopen, the worst appears to be behind us. API data will be in focus. Last week’s data showed a rise of 8.4 million barrels.

WTI Chart

Build your confidence risk free

More from Indices

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.